UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008981
Receipt number R000009329
Scientific Title Prospective comparative study of the Ex-PRESS mini glaucoma shunt with standard trabeculectomy.
Date of disclosure of the study information 2012/09/25
Last modified on 2024/05/01 14:14:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective comparative study of the Ex-PRESS mini glaucoma shunt with standard trabeculectomy.

Acronym

Efficacy of Ex-PRESS miniature glaucoma implant

Scientific Title

Prospective comparative study of the Ex-PRESS mini glaucoma shunt with standard trabeculectomy.

Scientific Title:Acronym

Efficacy of Ex-PRESS miniature glaucoma implant

Region

Japan


Condition

Condition

Open angle glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy and safety of Ex-PRESS mini shunt on Japanese glaucoma patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

IOP reduction

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Standard trabeculectomy

Interventions/Control_2

Trabeculectomy with Ex-PRESS mini shunt implantation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with open angle glaucoma

Key exclusion criteria

Angle-closure glaucoma
Uveitis

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Yoshiaki
Middle name
Last name KIUCHI

Organization

Hiroshima University

Division name

Dept. of Ophthahlmology

Zip code

7348551

Address

1-2-3 Kasumi Minamiku Hiroshima

TEL

082-257-5247

Email

ykiuchi@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Kana
Middle name
Last name Tokumo

Organization

Hiroshima University

Division name

Dept. of Ophthalmology

Zip code

7348551

Address

1-2-3 Kasumi Minamiku Hiroshima

TEL

082-257-5247

Homepage URL


Email

kanatokumo@hiroshima-u.ac.jp


Sponsor or person

Institute

Dept. of Ophthalmology
Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center in Hiroshima

Address

1-2-3 Kasumi Minamiku Hiroshima

Tel

0822575555

Email

protocol@cimr.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 09 Month 25 Day


Related information

URL releasing protocol

https://www.dovepress.com/getfile.php?fileID=92327

Publication of results

Published


Result

URL related to results and publications

https://www.dovepress.com/getfile.php?fileID=92327

Number of participants that the trial has enrolled

73

Results

A total of 73 patients, 30 in EXP and 43 in TLE groups, were in the study. No significant differences in baseline ocular or demographic characteristics were found between the groups. IOP showed no significant difference every 6 months. Success rates showed no difference during the 3-year follow-up between both groups. Glaucoma medications before surgery were associated with higher failure rates in TLE, not in EXP.

Results date posted

2024 Year 05 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Total, 30 eyes were treated with EX-PRESS implantation EXP group and 43 eyes with TLE TLE group. Patients who had mild-to-severe cataract underwent combined cataract surgery. All patients were Japanese. The mean follow-up periods were 25.9 and 23.8 months in the EXP and TLE groups, respectively. No differences were found in baseline IOP, sex ratio, age, and number of glaucoma medications between the EXP and TLE groups. In the EXP group, 22 patients received EXP surgery alone, 8 patients received combined EXP and cataract surgery, 29 patients received TLE surgery alone, and 14 patients received combined TLE and cataract surgery.

Participant flow

The study was conducted at the Department of Ophthalmology, Hiroshima University Hospital. Patients were enrolled between November 2012 and March 2015. They were followed up for 1 year, 3 years if possible. Patients were randomized to receive TLE or EXP using a computer-based random number generator. Random allocations were prepared by staff not associated with the study and they assigned participants to interventions. Clinicians enrolled the participants in this study. After patient enrollment was completed, only then the surgery to be performed was confirmed. Both patients and clinicians were aware of the therapy; therefore, this was an open-label, randomized study. The preoperative IOP and best-corrected visual acuity (VA) were recorded during the examination immediately before surgery. The IOP and VA were documented the day after surgery and at every follow-up visit. Postoperative IOP and VA values measured every 6 months for 3 years were included in the efficacy (surgical success) analysis. The surgical procedures and postoperative management were comparable for each case. Anesthesia included subconjunctival lidocaine injection. A fornix-based conjunctival flap was used, and a halfthickness scleral flap was created. Small pieces of gelatin sponge soaked with 0.4 mg/mL mitomycin C (MMC) were applied to the exposed tissue, including the posterior surface of Tenon's capsule and conjunctiva, adjacent episcleral tissue, and scleral flap for 5 min. After 5 min, all sponges were removed, and the wound was irrigated with 100 mL of a balanced salt solution. For the TLE group, a block incision was made in the region of the trabecular meshwork, followed by peripheral iridectomy. For the EXP group, a small scleral tunnel was created as a shunt in the region of the trabecular meshwork using a 25-G needle. In all cases in the EXP and TLE groups, the scleral flap was sutured using five 10-0 Nylon sutures, and the conjunctiva were closed using 10-0 Nylon sutures. Patients were treated with laser suture lysis if the IOP was higher than the target IOP. The target IOP for most patients was set at 8-10 mmHg 2 weeks postoperatively. All patients received a similar topical medical regimen, including postoperatively 1.5% levofloxacin and 0.1% topical betamethasone three times per day. Patients receiving combinedcataract surgery were also administered nepafenac three times a day. Topical atropine sulfate (1%) was used as needed.

Adverse events

At 1 month postoperatively, 13 patients in the EXP group and 10 patients in the TLE group developed early complications. These included hyphema, choroidal detachment, shallow anterior chamber, hypotony maculopathy, and conjunctiva leakage. Both groups had similar complications. No statistically significant difference was found in the total prevalence of early complications between the groups. Only the TLE group showed late postoperative complications, i.e., one case of choroidal detachment and one of conjunctiva leakage. However, no statistically significant difference was found in the prevalence of late complications between the groups.

Outcome measures

Intraocular pressure, surgical success rate, and complications.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 05 Month 14 Day

Date of IRB

2012 Year 08 Month 30 Day

Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date

2021 Year 08 Month 11 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 09 Month 25 Day

Last modified on

2024 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009329